FDA Approves Bemotrizinol, Expanding Sunscreen Options for U.S. Consumers
The U.S. Food and Drug Administration has approved bemotrizinol, a new sunscreen active ingredient, giving Americans an additional option for UV protection. This approval follows its earlier acceptance in Europe and Japan, marking a significant expansion in the range of available sunscreens in the U.S. market.